SEOUL, Dec. 9 (Korea Bizwire) — South Korea’s pharmaceutical giant Celltrion Inc. said Monday that it has received approval from Canadian health authorities for a biosimilar treatment for allergic asthma. The company said that its biosimilar, Omlyclo, a version of Xolair, has been approved by Health Canada, adding that studies have demonstrated its equivalent performance [...]
JEONJU, Aug. 4 (Korea Bizwire) — Jeonbuk National University Hospital announced on Wednesday that its researchers had succeeded in immunologically clarifying the presumed correlation between COVID-19 and severe asthma and the risk of their combination. The research team published the results of their study in the latest online edition of the international journal Allergy. The [...]
SEOUL, July 27 (Korea Bizwire) — Some 14,000 people were estimated to have died from a deadly humidifier sanitizer scandal that broke out in 2011, a figure that is roughly 10 times bigger than previously reported, a study showed Monday. The number of adults who died after being diagnosed as patients of relevant diseases, such [...]
SEOUL, April 10 (Korea Bizwire) — The deadline is April 20 to apply for monthly stipends of 250,000 won that will continue to be issued until the recipient turns 18. To be eligible for this benefit, the applicant must be a Seoul child of a low-income household who is 12 years old or younger and [...]